Overview
The Global AI In Endoscopy Market size is expected to be worth around USD 838.9 Million by 2033 from USD 58.1 Million in 2023, growing at a CAGR of 30.6% during the forecast period from 2024 to 2033.
The integration of Artificial Intelligence (AI) in endoscopy is significantly transforming gastrointestinal diagnostics and therapeutic procedures. By combining advanced imaging with machine learning algorithms, AI-assisted endoscopy enables real-time identification of abnormalities such as polyps, ulcers, bleeding sites, and early-stage cancers with enhanced accuracy and speed.
AI in endoscopy is particularly valuable in colorectal cancer screening, where Computer-Aided Detection (CADe) systems support gastroenterologists by highlighting potential lesions during colonoscopy. Several clinical studies have demonstrated that AI-assisted colonoscopy improves adenoma detection rates (ADR) by up to 14%, reducing the chances of missed lesions and thereby improving patient outcomes.
Furthermore, AI is enhancing workflow efficiency by enabling automated report generation, real-time image annotation, and the prioritization of urgent findings. These improvements reduce procedural time and enhance diagnostic consistency across operators and institutions.
The growing prevalence of gastrointestinal disorders, combined with the increasing demand for minimally invasive procedures and early cancer detection, is driving the global adoption of AI-integrated endoscopic platforms. According to leading healthcare institutions, AI-based diagnostic systems are expected to become standard practice in clinical gastroenterology within the next decade.
As the technology continues to evolve, collaborations between AI developers, endoscopy device manufacturers, and healthcare providers are expected to accelerate innovation, regulatory approvals, and clinical integration of intelligent endoscopy solutions.
Click here to get a Sample report copy @ https://market.us/report/ai-in-endoscopy-market/free-sample/
Key Takeaways
- The global AI in Endoscopy market was valued at USD 58.1 million in 2023 and is projected to surpass USD 838.9 million by 2033, expanding at a CAGR of 30.6% during the forecast period.
- Gastrointestinal endoscopy led all procedural types, accounting for 32.4% of total revenue. Its dominance is attributed to broad clinical use in diagnosing and managing ulcers, cancers, and other digestive disorders.
- Among component segments, Services held the largest share at 39.7%, driven by increased demand for external support in the deployment, training, and management of AI-powered endoscopic solutions.
- Within computer-aided detection (CAD) applications, CADx (Computer-Aided Diagnosis) maintained a leadership position with a 43.0% share, reflecting its value in enhancing diagnostic precision and clinician confidence through algorithm-based interpretation.
- Hospitals remained the largest end-user group, capturing 58.2% of the market. This dominance stems from their central role in delivering specialized care and integrating advanced diagnostic technologies into clinical workflows.
- North America continued to lead the global market, securing 48.7% of total revenue, supported by well-established healthcare infrastructure, robust research investment, and early technology adoption.
Segmentation Analysis
- Type Analysis: Gastrointestinal endoscopy accounted for 32.4% of total revenue, emerging as the leading segment. Its dominance is driven by its essential role in diagnosing and treating digestive disorders, including ulcers, polyps, and cancers. This procedure enables real-time visualization of the gastrointestinal tract, enhancing early disease detection and targeted interventions. With technological advances and rising preventive health awareness, demand for GI endoscopy continues to grow across both diagnostic and therapeutic applications.
- Component Analysis: The Services segment led the market with a 39.7% revenue share, reflecting a growing dependence on external expertise for AI deployment. Services include consulting, implementation, training, and support, which are critical for integrating complex AI systems in endoscopy workflows. As AI technology evolves, healthcare providers increasingly seek skilled partners to ensure seamless integration, reduce operational risk, and maximize clinical benefits, driving continued expansion of the services segment.
- CAD Analysis: CADx (Computer-Aided Diagnosis) retained its leading position, capturing a 43.0% share of the CAD analysis market. CADx systems leverage advanced algorithms and image processing techniques to enhance diagnostic interpretation and accuracy. Widely applied across modalities such as X-ray, MRI, and CT, CADx supports early disease identification, improving clinical outcomes. Its ability to standardize image assessment and reduce diagnostic error underpins its growing adoption in AI-assisted endoscopy.
- End-User Analysis: Hospitals dominated the end-user landscape, securing 58.2% of market revenue, due to their central role in healthcare delivery. As primary hubs for diagnostics, treatment, and research, hospitals are well-positioned to integrate AI-enhanced endoscopic tools. Their extensive infrastructure, multidisciplinary capabilities, and focus on quality care and innovation make them the key adopters of intelligent diagnostic technologies, further strengthening their market leadership in AI-based endoscopy.
Market Segments
Type of Endoscopy
- Gastrointestinal Endoscopy
- Bronchoscopy
- Colonoscopy
- Laparoscopy
- Others
Component
- Hardware
- Software
- Services
Type of CAD
- CADx
- CADe
- Others
End-User
- Hospitals
- Ambulatory Surgical Centers
- Others
To Purchase this Premium Report @ https://market.us/purchase-report/?report_id=116455
Regional Analysis
In 2023, North America led the global AI in Endoscopy market, accounting for 48.7% of total revenue. The region’s dominance is supported by a highly developed healthcare infrastructure, strong investment in AI technologies, and favorable regulatory policies that encourage innovation and early adoption of advanced diagnostic tools.
Europe continues to witness steady growth, driven by rising healthcare expenditure and increased preference for minimally invasive diagnostic procedures.
Meanwhile, the Asia-Pacific region presents significant growth potential due to improving healthcare infrastructure, greater awareness of preventive diagnostics, and proactive government initiatives promoting the adoption of AI-driven medical technologies. These regional trends collectively underscore the global momentum behind AI integration in endoscopic practices.
Key Players Analysis
The AI in endoscopy market features a competitive environment marked by the presence of established medical device manufacturers and innovative emerging players. Olympus Corporation, Medtronic plc, and Boston Scientific Corporation are among the key industry leaders, actively integrating AI technologies into their endoscopic platforms. These companies prioritize research and development to advance diagnostic accuracy, procedural efficiency, and clinical outcomes.
In addition, emerging players such as CapsoVision, NinePoint Medical, and Pentax Medical are contributing to market innovation through AI-driven solutions focused on early disease detection and real-time procedural support. Their efforts underscore the growing emphasis on precision diagnostics and the expanding role of AI in next-generation endoscopic systems.
Market Key Players
- Medtronic
- Wision Al
- Olympus Corporation
- Fujifilm Corporation
- Pentax Corporation
- NEC Corporation
- Odin Vision
- Magentiq Eye Ltd.
- Wuhan EndoAngel Medical Technology
- Iterative Scopes
- Other Key Players
Market Dynamics
- Market Driver: The primary driver of the AI in endoscopy market is the rising demand for early and accurate diagnosis of gastrointestinal disorders. AI-powered systems enhance lesion detection, reduce oversight, and support clinical decision-making. This improves patient outcomes and procedural efficiency, driving hospital and clinical adoption. Coupled with the global rise in digestive diseases, the need for more precise and efficient diagnostic tools continues to push the growth of AI integration in endoscopic procedures.
- Market Trend: A key trend in the AI in endoscopy market is the integration of real-time computer-aided detection (CADe) and diagnosis (CADx) systems. These technologies assist clinicians during procedures by highlighting abnormalities and offering instant diagnostic suggestions. Additionally, growing use of cloud-based platforms and remote diagnostics is making AI solutions more scalable. Manufacturers are increasingly embedding AI features directly into endoscopy devices, reflecting a shift toward fully integrated, intelligent imaging systems that streamline workflows and enhance diagnostic reliability.
- Market Opportunity: Significant market opportunity lies in the expansion of AI endoscopy solutions in emerging markets such as Asia-Pacific, Latin America, and parts of the Middle East. These regions are witnessing improvements in healthcare infrastructure, rising adoption of minimally invasive diagnostics, and increasing government support for digital health innovations. Moreover, the unmet need for early disease detection and limited access to experienced clinicians in rural areas create a strong case for scalable, AI-assisted endoscopic tools.
Conclusion
The AI in Endoscopy market is undergoing rapid transformation, driven by advancements in intelligent imaging, growing demand for early diagnosis, and increasing adoption of minimally invasive procedures. With a projected CAGR of 30.6% through 2033, the market is poised for substantial growth. North America leads in adoption, while Asia-Pacific presents strong future potential.
Major players and emerging innovators are driving technological evolution, particularly in CADx systems and service integration. As clinical acceptance expands and infrastructure strengthens globally, AI-assisted endoscopy is expected to become a cornerstone of precision diagnostics and gastrointestinal healthcare delivery in the coming decade.
View More Reports:
Healthcare Fraud Analytics Market Gains Momentum with 23.5% CAGR Forecast
Healthcare Fraud Analytics Market Gains Momentum with 23.5% CAGR Forecast
Hospital Logistics Robots Market Projected to Hit USD 18.4 Billion by 2033
Hospital Logistics Robots Market Projected to Hit USD 18.4 Billion by 2033
3D Medical Implants Market Forecasted to Grow at 12.7% CAGR Through 2033
3D Medical Implants Market Forecasted to Grow at 12.7% CAGR Through 2033
